KCR
KCR is a privately held, Berlin-based Contract Research Organization founded in 1997 that delivers clinical development solutions to pharmaceutical and biotechnology sponsors, with a workforce of 501-1,000 employees.
- Company typePrivate
- Founded1997
- HeadquartersBerlin, Germany
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What KCR does
KCR is a privately held Contract Research Organization (CRO) headquartered in Berlin, Germany, founded in 1997. The firm provides clinical development solutions to pharmaceutical and biotechnology sponsors, operating in the mid-tier CRO segment with a workforce of 501-1,000 employees. Its corporate website is kcrcro.com and its senior leadership comprises Mike Jagielski as President & CEO and Doug Bain as Chief Technology Officer. Beyond these firmographic anchors, no specific therapeutic-area focus, service-line mix, technology platform, geographic footprint beyond Berlin, pricing model, or named customer references are documented in the available source material.
The supplied input set contains substantial noise that does not pertain to KCR the CRO: multiple source blocks refer to K. Chandrashekar Rao, a former Chief Minister of Telangana, India, in the context of legal and political matters including the PC Ghose Commission investigation of the Kaleshwaram Lift Irrigation Project, a phone-tapping SIT matter, and CBI handover discussions; an additional block reproduces the ICON plc website content for biotech outsourcing services. These sources are unrelated to KCR GmbH/KCR CRO and have been excluded from substantive analysis. No funding rounds, acquisitions, partnerships, product launches, regulatory milestones, or customer disclosures attributable to KCR the CRO were extractable.
Given the thinness of first-party evidence, the company should be characterized as an established, mid-sized European CRO with 28 years of operating history, a Berlin cost base, and standard CRO service delivery — with all other strategic, financial, and competitive dimensions flagged as data gaps rather than inferred.
KCR firmographics
Firmographics- Name
- KCR
- Legal name
- KCR (K. Chandrashekar Rao)
- Website
- https://kcrcro.com
- Company type
- Private
- Founded year
- 1997
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- KCR is a privately held, Berlin-based Contract Research Organization founded in 1997 that delivers clinical development solutions to pharmaceutical and biotechnology sponsors, with a workforce of 501-1,000 employees.
- Ownership category
- akta.pro rank
KCR industry classification
Industry- Product category
- Contract Research Organization Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
Keywords
Where KCR is headquartered
LocationHeadquarters
- HQ city
- Berlin
- HQ country
- Germany
- HQ region
- Europe
Markets served
KCR business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
KCR product offering
Product offeringCore offering
KCR is a Contract Research Organization (CRO) that provides clinical development solutions to pharmaceutical and biotechnology sponsors. Headquartered in Berlin, Germany and founded in 1997, the firm supports clinical trial execution and related development activities for biopharma clients.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Development Solutions CRO services spanning the clinical development lifecycle, provided to pharmaceutical and biotechnology sponsors. Delivered from the Berlin, Germany headquarters.
Companies that use KCR
Customer profileIdeal customer profiles1 record
KCR technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
KCR competitors and assessment
Company assessmentDirect peers
- ICON plc: Global clinical CRO with end-to-end Phase I–IV services across biotech and pharma sponsors; directly comparable to KCR as a clinical development outsourcing competitor, though operating at materially larger scale.
- Parexel International: Mid-to-large clinical CRO focused on biotech and biopharma sponsors; directly comparable operating model to KCR with similar therapeutic-area clinical development emphasis.
- Medpace Holdings: Mid-sized full-service CRO with concentrated biotech sponsor focus and strong operational execution reputation; highly comparable in scale and clinical development positioning to KCR.
- Worldwide Clinical Trials: Mid-sized, therapeutically-focused clinical CRO with strong CNS, cardiometabolic, and rare disease franchises; comparable to KCR in scale and clinical development service model.
- CTI Clinical Trial & Consulting Services: Mid-sized private CRO headquartered in Cincinnati with strong European delivery footprint; directly comparable to KCR in size, therapeutic focus, and clinical development offering.
- Fortrea Holdings: Mid-to-large clinical CRO carved out from Labcorp Drug Development; competes directly with KCR for Phase II–IV clinical trial work across biotech and pharma sponsors.
- Syneos Health: Clinical CRO and commercial solutions provider; directly comparable to KCR as a clinical development outsourcing peer, with broader commercial/launch services as a distinguishing feature.
- Clinscience (previously Clinipace Worldwide): Mid-sized, therapeutically-focused clinical CRO with European operational roots; comparable to KCR in scale, therapeutic focus, and clinical development service model.
Broad incumbents
- IQVIA: Largest global CRO/clinical technology player with R&D Solutions and broader data/analytics offerings; competes with KCR for Phase II–III clinical trial work while also offering adjacent commercial and real-world evidence services.
- Charles River Laboratories: Broader life sciences services platform spanning preclinical through clinical; competes with KCR particularly at the preclinical-clinical handoff and through its clinical CRO subsidiary.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat2 records
Key risks4 records
Key highlights4 records
Customer concentration
KCR social profiles
Digital presenceKCR financial estimates
Financial estimateRevenue estimate
Valuation estimate
KCR leadership team
Management profileNumber of profiles
Profiles2 records
KCR funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
KCR M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about KCR
What does KCR do?
KCR is a Contract Research Organization (CRO) that provides clinical development solutions to pharmaceutical and biotechnology sponsors. Headquartered in Berlin, Germany and founded in 1997, the firm supports clinical trial execution and related development activities for biopharma clients.
Is KCR a public or private company?
KCR is a private company. It is classified as unknown and is currently operating.
When was KCR founded?
KCR was founded in 1997. It employs 501 to 1,000 people.
Where is KCR based?
KCR is headquartered in Berlin, Germany, in the Europe region.
Who are KCR's main competitors?
Direct peers on record are ICON plc, Parexel International, Medpace Holdings, Worldwide Clinical Trials, CTI Clinical Trial & Consulting Services, Fortrea Holdings, Syneos Health and Clinscience (previously Clinipace Worldwide). Broad incumbents are IQVIA and Charles River Laboratories.
Does KCR have an API?
No public API is recorded for KCR.
What industry is KCR in?
KCR's product category is Contract Research Organization Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV). Its NAICS code is 541714 and its SIC code is 8731.